Eagle Pharmaceut (EGRX) Free Cash Flow by Year
Eagle Pharmaceut generated $50.5M in free cash flow in fiscal year 2022. This represents an increase of 81.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2022 through Q2 FY2023, the same line adds up to an outflow of $9.4M in free cash flow. The table below carries 11 fiscal years, from 2012 to 2022, and the quarters Eagle Pharmaceut has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
EGRX Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
EGRX Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Eagle Pharmaceut financials
Frequently Asked Questions
What was Eagle Pharmaceut's free cash flow in fiscal year 2022?
Eagle Pharmaceut generated $50.5M in free cash flow in fiscal year 2022.
How fast is Eagle Pharmaceut's free cash flow growing?
Eagle Pharmaceut (EGRX) free cash flow rose by 81.1% year over year, from $27.9M to $50.5M in fiscal year 2022.
What is Eagle Pharmaceut's free cash flow over the last twelve months?
Eagle Pharmaceut (EGRX) reported an outflow of $9.4M in free cash flow over the trailing 12 months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
How has Eagle Pharmaceut's free cash flow changed over the years?
Across the 11 fiscal years this page covers, Eagle Pharmaceut (EGRX) free cash flow went from -$15.6M in fiscal year 2012 to $50.5M in fiscal year 2022.
What was Eagle Pharmaceut's free cash flow in the most recent quarter?
Eagle Pharmaceut (EGRX) reported -$132K in free cash flow in Q2 2023. This represents a decrease of 100.3% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Eagle Pharmaceut (EGRX) reported on that line in every period on record.